Occupational interstitial lung diseases.
asbestosis
hypersensitivity pneumonitis
idiopathic pulmonary fibrosis
interstitial lung disease
occupational exposure
pneumoconiosis
silicosis
Journal
Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
13
11
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
Millions of workers are exposed to substances known to cause occupational interstitial lung diseases (ILDs), particularly in developing countries. However, the burden of the disease is likely to be underestimated due to under-recognition, under-reporting or both. The diagnosis of occupational ILD requires a high level of suspicion and a thorough occupational history, as occupational and non-occupational ILDs may be clinically, functionally and radiologically indistinguishable, leading to delayed diagnosis and inappropriate management. A potential occupational aetiology should always be considered in the differential diagnosis of ILD, as removal from the workplace exposure, with or without treatment, is a key therapeutic intervention and may lead to significant improvement. In this article, we provide an overview of the 'traditional' inorganic dust-related ILDs but also address idiopathic pulmonary fibrosis and the immunologically mediated chronic beryllium disease, sarcoidosis and hypersensitivity pneumonitis, with emphasis on the importance of surveillance and prevention for reducing the burden of these conditions. To this end, health-care professionals should be specifically trained about the importance of occupational exposures as a potential cause of ILD.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
798-815Informations de copyright
© 2023 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
Références
Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733-48.
Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The occupational burden of nonmalignant respiratory diseases. An official American thoracic society and European respiratory society statement. Am J Respir Crit Care Med. 2019;199:1312-34.
Occupational Interstitial Lung Disease. https://www.dir.ca.gov/dwc/DWCPropRegs/2020/MTUS-Evidence-Based-Updates-June-2020/Occupational-Interstitial-Lung-Disease.pdf
Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150:967-72.
Mcdonald JC. Incidence by occupation and industry of acute work related respiratory diseases in the UK, 1992-2001. Occup Environ Med. 2005;62:836-42.
Barber CM, Wiggans RE, Carder M, Agius R. Epidemiology of occupational hypersensitivity pneumonitis; reports from the SWORD scheme in the UK from 1996 to 2015. Occup Environ Med. 2017;74:528-30.
Fenclová Z, Pelclová D, Urban P, Navrátil T, Klusáčková P, Lebedová J. Occupational hypersensitivity pneumonitis reported to the Czech national registry of occupational diseases in the period 1992-2005. Ind Health. 2009;47:443-8.
Rosenman KD, Reilly MJ, Henneberger PK. Estimating the total number of newly-recognized silicosis cases in the United States. Am J Ind Med. 2003;44:141-7.
Carder M, Darnton A, Gittins M, Stocks SJ, Ross D, Barber CM, et al. Chest physician-reported, work-related, long-latency respiratory disease in Great Britain. Eur Respir J. 2017;50:1700961.
Shi P, Xing X, Xi S, Jing H, Yuan J, Fu Z, et al. Trends in global, regional and national incidence of pneumoconiosis caused by different aetiologies: an analysis from the Global Burden of Disease Study 2017. Occup Environ Med. 2020;77:407-14.
Li J, Yin P, Wang H, Wang L, You J, Liu J, et al. The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019. BMC Public Health. 2022;22:1114.
Wang D, Liang R, Yang M, Ma J, Li W, Mu M, et al. Incidence and disease burden of coal workers’ pneumoconiosis worldwide, 1990-2019: evidence from the Global Burden of Disease Study 2019. Eur Respir J. 2021;58:2101669.
Tjoe Nij E. Radiographic abnormalities among construction workers exposed to quartz containing dust. Occup Environ Med. 2003;60:410-7.
Akgun M, Araz O, Akkurt I, Eroglu A, Alper F, Saglam L, et al. An epidemic of silicosis among former denim sandblasters. Eur Respir J. 2008;32:1295-303.
Nandi SS, Dhatrak SV, Sarkar K. Silicosis, progressive massive fibrosis and silico-tuberculosis among workers with occupational exposure to silica dusts in sandstone mines of Rajasthan state: an urgent need for initiating national silicosis control programme in India. J Family Med Prim Care. 2021;10:686-91.
https://www.cdc.gov/niosh/topics/surveillance/ords/nationalstatistics.html
Goswami E, Craven V, Dahlstrom D, Alexander D, Mowat F. Domestic asbestos exposure: a review of epidemiologic and exposure data. Int J Environ Res Public Health. 2013;10:5629-70.
Moore I, Wrobel J, Rhodes J, Lin Q, Webster S, Jo H, et al. Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database. BMC Pulm Med. 2020;20:257.
Jindal SK. Silicosis in India: past and present. Curr Opin Pulm Med. 2013;19:163-8.
Kaul B, Cottin V, Collard HR, Valenzuela C. Variability in global prevalence of interstitial lung disease. Front Med (Lausanne). 2021;8:751181.
Dos S Antao VC. Rapidly progressive coal workers’ pneumoconiosis in the United States: geographic clustering and other factors. Occup Environ Med. 2005;62:670-4.
Leso V, Fontana L, Romano R, Gervetti P, Iavicoli I. Artificial stone associated silicosis: a systematic review. Int J Environ Res Public Health. 2019;16:568.
Pérez-Alonso A, Córdoba-Doña JA, Millares-Lorenzo JL, Figueroa-Murillo E, García-Vadillo C, Romero-Morillo J. Outbreak of silicosis in Spanish quartz conglomerate workers. Int J Occup Environ Health. 2014;20:26-32.
Hoy RF, Baird T, Hammerschlag G, Hart D, Johnson AR, King P, et al. Artificial stone-associated silicosis: a rapidly emerging occupational lung disease. Occup Environ Med. 2018;75:3-5.
Kramer MR, Blanc PD, Fireman E, Amital A, Guber A, Rhahman NA, et al. Artificial stone silicosis [corrected]: disease resurgence among artificial stone workers. Chest. 2012;142:419-24.
León-Jiménez A, Hidalgo-Molina A, Conde-Sánchez MÁ, Pérez-Alonso A, Morales-Morales JM, García-Gámez EM, et al. Artificial stone silicosis: rapid progression following exposure cessation. Chest. 2020;158:1060-8.
Cooper JH, Johnson DL, Phillips ML. Respirable silica dust suppression during artificial stone countertop cutting. Ann Occup Hyg. 2015;59:122-6.
Cohen RA, Petsonk EL, Rose C, Young B, Regier M, Najmuddin A, et al. Lung pathology in U.S. coal workers with rapidly progressive pneumoconiosis implicates silica and silicates. Am J Respir Crit Care Med. 2016;193:673-80.
GBD 2016 Occupational Chronic Respiratory Risk Factors Collaborators. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. Occup Environ Med. 2020;77:142-50.
Chen S, Liu M, Xie F. Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the global burden of disease study 2019. BMC Pulm Med. 2022;22:240.
Mckee AS, Atif SM, Falta MT, Fontenot AP. Innate and adaptive immunity in noninfectious granulomatous lung disease. J Immunol. 2022;208:1835-43.
Fontenot A, Maier L. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Trends Immunol. 2005;26:543-9.
Mccanlies EC. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol. 2003;157:388-98.
Henneberger PK, Goe SK, Miller WE, Doney B, Groce DW. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J Occup Environ Hyg. 2004;1:648-59.
Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med. 1989;320:1103-9.
Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with “memory”-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med. 1990;171:1123-40.
Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest. 2002;110:1473-82.
Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993;262:242-4.
Richeldi L, Kreiss K, Mroz MM, Zhen B, Tartoni P, Saltini C. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med. 1997;32:337-40.
Potolicchio I, Mosconi G, Forni A, Nemery B, Seghizzi P, Sorrentino R. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain. Eur J Immunol. 1997;27:2741-3.
Terho EO, Heinonen OP, Lammi S. Incidence of farmer's lung leading to hospitalization and its relation to meteorological observations in Finland. Acta Med Scand. 1983;213:295-8.
Depierre A, Dalphin JC, Pernet D, Dubiez A, Faucompre C, Breton JL. Epidemiological study of farmer's lung in five districts of the French Doubs province. Thorax. 1988;43:429-35.
Grant IWB, Blyth W, Wardrop VE, Gordon RM, Pearson JCG, Mair A. Prevalence of farmer's lung in Scotland: a pilot survey. BMJ. 1972;1:530-4.
Barnes H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Hypersensitivity pneumonitis: current concepts in pathogenesis, diagnosis, and treatment. Allergy. 2022;77:442-53.
Sanderson W, Kullman G, Sastre J, Olenchock S, O'campo A, Musgrave K, et al. Outbreak of hypersensitivity pneumonitis among mushroom farm workers. Am J Ind Med. 1992;22:859-72.
Woodard ED. Outbreak of hypersensitivity pneumonitis in an industrial setting. JAMA. 1988;259:1965-9.
Cummings KJ, Stanton ML, Nett RJ, Segal LN, Kreiss K, Abraham JL, et al. Severe lung disease characterized by lymphocytic bronchiolitis, alveolar ductitis, and emphysema (BADE) in industrial machine-manufacturing workers. Am J Ind Med. 2019;62:927-37.
Fernández Pérez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni R, Cole AL. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Ann Am Thorac Soc. 2018;15:460-9.
Quirce S, Vandenplas O, Campo P, Cruz MJ, De Blay F, Koschel D, et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71:765-79.
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P-Y, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155-67.
Oliver LC, Zarnke AM. Sarcoidosis: an occupational disease? Chest. 2021;160:1360-7.
Newman KL, Newman LS. Occupational causes of sarcoidosis. Curr Opin Allergy Clin Immunol. 2012;12:145-50.
Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324-30.
Barnard J, Rose C, Newman L, Canner M, Martyny J, Mccammon C, et al. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of Sarcoidosis (ACCESS). J Occup Environ Med. 2005;47:226-34.
Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, Aldrich TK, et al. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007;131:1414-23.
Beijer E, Meek B, Bossuyt X, Peters S, Vermeulen RCH, Kromhout H, et al. Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients. Respir Res. 2020;21:141.
Park Y, Ahn C, Kim T-H. Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses. Sci Rep. 2021;11:4318.
Abramson MJ, Murambadoro T, Alif SM, Benke GP, Dharmage SC, Glaspole I, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study. Thorax. 2020;75:864-9.
Paolocci G, Folletti I, Torén K, Ekström M, Dell'omo M, Muzi G, et al. Occupational risk factors for idiopathic pulmonary fibrosis in Southern Europe: a case-control study. BMC Pulm Med. 2018;18:75.
Lee CT, Adegunsoye A, Chung JH, Ventura IB, Jablonski R, Montner S, et al. Characteristics and prevalence of domestic and occupational inhalational exposures across interstitial lung diseases. Chest. 2021;160:209-18.
Lee CT, Strek ME, Adegunsoye A, Wong AW, Assayag D, Cox G, et al. Inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022;27:635-44.
Lee CT, Feary J, Johannson KA. Environmental and occupational exposures in interstitial lung disease. Curr Opin Pulm Med. 2022;28:414-20.
Shtraichman O, Blanc PD, Ollech JE, Fridel L, Fuks L, Fireman E, et al. Outbreak of autoimmune disease in silicosis linked to artificial stone. Occup Med (Lond). 2015;65:444-50.
Freire M, Alonso M, Rivera A, Sousa A, Soto A, Gómez-Sousa JM, et al. Clinical peculiarities of patients with scleroderma exposed to silica: a systematic review of the literature. Semin Arthritis Rheum. 2015;45:294-300.
Sack CS, Doney BC, Podolanczuk AJ, Hooper LG, Seixas NS, Hoffman EA, et al. Occupational exposures and subclinical interstitial lung disease. The MESA (multi-ethnic study of atherosclerosis) air and lung studies. Am J Respir Crit Care Med. 2017;196:1031-9.
Blanco-Pérez JJ, Arnalich-Montiel V, Salgado-Barreira Á, Alvarez-Moure MA, Caldera-Díaz AC, Melero-Gonzalez R, et al. Prevalence and clinical impact of systemic autoimmune rheumatic disease in patients with silicosis. Arch Bronconeumol. 2021;57:571-6.
Salisbury ML, Hewlett JC, Ding G, Markin CR, Douglas K, Mason W, et al. Development and progression of radiologic abnormalities in individuals at risk for familial interstitial lung disease. Am J Respir Crit Care Med. 2020;201:1230-9.
Copeland CR, Donnelly EF, Mehrad M, Ding G, Markin CR, Douglas K, et al. The association between exposures and disease characteristics in familial pulmonary fibrosis. Ann Am Thorac Soc. 2022;19:2003-12.
Minette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms. 1987-updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Respir J. 1989;2:165-77.
Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. 1991;85(Suppl B):25-31.
Carlier S, Nasser M, Fort E, Lamouroux C, Si-Mohamed S, Chalabreysse L, et al. Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases. Respir Res. 2022;23:332.
Barnes H, Glaspole I. Occupational interstitial lung diseases. Immunol Allergy Clin North Am. 2023;43:323-39.
Johannson KA, Barnes H, Bellanger A-P, Dalphin J-C, Fernández Pérez ER, Flaherty KR, et al. Exposure assessment tools for hypersensitivity pneumonitis. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2020;17:1501-9.
Hoffman TW, Van Es HW, Biesma DH, Grutters JC. Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis. BMC Pulm Med. 2022;22:329.
Litow FK, Lee Petsonk E, Bohnker BK, Brodkin CA, Cowl CT, Guidotti TL, et al. Occupational interstitial lung diseases. J Occup Environ Med. 2015;57:1250-4.
Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol. 1985;147:107-19.
Copley SJ, Wells AU, Sivakumaran P, Rubens MB, Gary Lee YC, Desai SR, et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology. 2003;229:731-6.
Monsó E, Tura J, Pujadas J, Morell F, Ruiz J, Morera J. Lung dust content in idiopathic pulmonary fibrosis: a study with scanning electron microscopy and energy dispersive x ray analysis. Br J Ind Med. 1991;48:327-31.
Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, et al. Pathology of asbestosis-an update of the diagnostic criteria: report of the asbestosis committee of the college of American pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010;134:462-80.
Churg A, Vedal S. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med. 1994;150:663-9.
Churg A. Asbestos-related disease in the workplace and the environment: controversial issues. Monogr Pathol. 1993;36:54-77.
Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis. 1991;144:689-96.
Churg A, Wright JL, Vedal S. Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. Am Rev Respir Dis. 1993;148:25-31.
Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med. 2010;181:458-64.
Marchiori E, Souza CA, Barbassa TG, Escuissato DL, Gasparetto EL, Souza AS. Silicoproteinosis: high-resolution CT findings in 13 patients. AJR Am J Roentgenol. 2007;189:1402-6.
Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, et al. Hypersensitivity pneumonitis: a comprehensive review. Investig Allergol Clin Immunol. 2015;25:237-50.
Laney AS, Weissman DN. Respiratory diseases caused by coal mine dust. J Occup Environ Med. 2014; 56(Suppl), S18-22.
Akpinar-Elci M, Travis WD, Lynch DA, Kreiss K. Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur Respir J. 2004;24:298-302.
Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HMH, et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med. 2008;102:825-30.
Cox CW, Rose CS, Lynch DA. State of the art: imaging of occupational lung disease. Radiology. 2014;270:681-96.
Kern DG 3rd. Flock worker's lung: chronic interstitial lung disease in the nylon flocking industry. Ann Intern Med. 1998;129:261-72.
Weiland DA, Lynch DA, Jensen SP, Newell JD, Miller DE, Crausman RS, et al. Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease. Radiology. 2003;227:222-31.
Hines SE, Pacheco K, Maier LA. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease. Curr Opin Allergy Clin Immunol. 2012;12:102-10.
Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005;171:54-60.
Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, et al. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014;190:e34-59.
Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J. 2011;38:761-9.
De Vuyst P, Karjalainen A, Dumortier P, Pairon J, Monso E, Brochard P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS working group. Eur Respir J. 1998;11:1416-26.
Kido T, Morimoto Y, Yatera K, Ishimoto H, Ogoshi T, Oda K, et al. The utility of electron microscopy in detecting asbestos fibers and particles in BALF in diffuse lung diseases. BMC Pulm Med. 2017;17:71.
Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2020;8:171-81.
https://www.dir.ca.gov/dwc/DWCPropRegs/2020/MTUS-Evidence-Based-Updates-June-2020/Occupational-Interstitial-Lung-Disease.pdf
Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Pulmonary sarcoidosis Lancet Respir Med. 2018;6:389-402.
Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58:2004079.
Ryerson CJ, Corte TJ, Myers JL, Walsh SLF, Guler SA. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease. Eur Respir J. 2021;58:2100276.
Stafford M, Cappa A, Weyant M, Lara A, Ellis J, Weitzel NS, et al. Treatment of acute silicoproteinosis by whole-lung lavage. Semin Cardiothorac Vasc Anesth. 2013;17:152-9.
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022; 205: e18-47.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381:1718-27.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med. 2020;8:453-60.
Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, et al. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2020;8:147-57.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, et al. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med. 2021;9:476-86.
Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med. 2005;11:169-73.
Sato T, Shimosato T, Klinman DM Silicosis and lung cancer: current perspectives. Lung Cancer (Auckl). 2018;9:91-101.
Rubio-Rivas M, Moreno R, Corbella X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol. 2017;36:569-82.
Amin W, Linkov F, Landsittel DP, Silverstein JC, Becich MJ. Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. F1000Research. 2018;7:1184.
Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-Part C: Metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10:453-4.
Caplan A, Payne RB, Withey JL. A broader concept of Caplan's syndrome related to rheumatoid factors. Thorax. 1962;17:205-12.
Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383:958-68.
Schulte PA. Characterizing the burden of occupational injury and disease. J Occup Environ Med. 2005;47:607-22.
Goldyn S, Condos R, Rom W. The burden of exposure-related diffuse lung disease. Semin Respir Crit Care Med. 2008;29:591-602.
https://www.cdc.gov/niosh/topics/hierarchy/default.html
https://www.cdc.gov/niosh/topics/spirometry/spirola-software.html